ArticleRadiation oncology (London, England)2022

Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.

Ioana M Marinescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.